School of Medicine
Showing 921-940 of 946 Results
-
Andrea Murray
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioAndrea Murray, MD is currently a Clinical Associate Professor for the Department of Anesthesia, Perioperative and Pain Medicine at Stanford University and is board-certified in Pediatric Anesthesiology, Internal Medicine, and in Pediatrics. Her interests include sustainable models in global health, regional anesthesia, simulation, and immersive technology for reduction of perioperative anxiety. She is deeply passionate about medical education and is dedicated to mentoring the next generation of physicians.
-
Lucas Murray
Postdoctoral Scholar, Biochemistry
Current Research and Scholarly InterestsI use single-molecule tools and approaches to study the assembly and function of molecular machines. I currently am working to understand the interplay between genome structure and kinetochore assembly and function in vertebrates.
-
Adam J. Murrietta, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Adam J. Murrietta is a fellowship-trained orthopaedic surgeon with Stanford Health Care. He is also a clinical assistant professor in the Department of Orthopaedic Surgery at Stanford University School of Medicine.
Dr. Murrietta diagnoses and treats a wide range of bone and joint conditions, including arthritis, bursitis, fractures, and infections. As an orthopaedic surgeon, he specializes in joint replacement surgery, with a focus on hip and knee replacements. He has advanced expertise in minimally invasive techniques, robotic-assisted procedures, and outpatient joint replacement. Additionally, Dr. Murrietta has extensive training in the latest surgical technologies and uses these innovations to reduce pain and enhance outcomes for his patients.
Dr. Murrietta’s research focuses on improving surgical outcomes and the treatment and management of orthopaedic injuries. His ongoing work focuses on joint replacement techniques and patient-reported outcomes. His research has been published in peer-reviewed journals, including The Journal of Arthroplasty, The Bone & Joint Journal, and Journal of the American Academy of Orthopaedic Surgeons. He has also presented his findings at regional and national conferences, including annual meetings of the Western Orthopaedic Association and the American Association of Hip and Knee Surgeons.
Dr. Murrietta is a fellow of the American Association of Hip and Knee Surgeons (AAHKS) and the American Academy of Orthopaedic Surgeons (AAOS). He is also a member of the American Medical Association (AMA) and the Western Orthopaedic Association (WOA). -
Mark Musen
Stanford Medicine Professor of Biomedical Informatics Research, Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsModern science requires that experimental data—and descriptions of the methods used to generate and analyze the data—are available online. Our laboratory studies methods for creating comprehensive, machine-actionable descriptions both of data and of experiments that can be processed by other scientists and by computers. We are also working to "clean up" legacy data and metadata to improve adherence to standards and to facilitate open science broadly.
-
Adel Mutahar
Postdoctoral Scholar, General and Vascular Surgery
BioDr. Adel Z. I. Mutahar is a postdoctoral researcher in the Department of Surgery at Stanford University, working under the mentorship of Dr. Frederick M. Dirbas. His research focuses on translational breast cancer biology and emerging radiotherapy technologies, with an emphasis on tumor–microenvironment interactions, immuno-oncology, and preclinical therapeutic development. His academic journey spans three countries—beginning in Yemen, advancing through India, and now progressing at Stanford—reflecting his commitment to impactful cancer research and global scientific advancement.
Dr. Mutahar began his career in Yemen, earning his Bachelor’s degree in Medical Laboratory Sciences before joining Abs Community College as a faculty member. From 2007–2013, he held several academic leadership roles, including Academic Director, Head of Evaluation, and Assistant Dean of Students, where he modernized curriculum, expanded hands-on diagnostic training, and strengthened laboratory education infrastructure in resource-limited settings. His work contributed to building a more skilled medical diagnostics workforce and improving pathways for laboratory science education.
Awarded a prestigious national merit scholarship, Dr. Mutahar continued his graduate and doctoral training in India, completing his M.S. and Ph.D. in Biotechnology with a focus on triple-negative breast cancer. During his doctoral work, he developed 3D tumor spheroid models and combinatorial therapeutic strategies, demonstrating synergy between anti-angiogenic agents and chemotherapy in TNBC. He further advanced this research by creating an orthotopic murine model to investigate metastatic progression and demonstrated that knockdown of the MTA1 gene in mesenchymal stem cells (MSCs) significantly suppressed TNBC invasion, angiogenesis, and metastatic spread, introducing a promising stromal-targeted therapeutic concept for aggressive breast cancer. This work earned recognition through travel grants, conference presentations, and a Best Poster Award. His scientific adaptability was further demonstrated during the COVID-19 pandemic, when he uncovered a novel interaction between SARS-CoV-2 Spike RBD and VEGF signaling.
At Stanford, his work emphases on FLASH radiotherapy, an ultrahigh-dose-rate modality with the potential to widen the therapeutic window by minimizing normal-tissue toxicity while maintaining tumor control. Working within Dr. Dirbas’s translational breast oncology program, Dr. Mutahar employs patient-derived xenografts, orthotopic murine models, spatial transcriptomics, single-cell RNA sequencing, and immune profiling to dissect the biological mechanisms governing treatment response. His research integrates multi-omics analysis to map early and late radiotherapy injury pathways—including senescence, apoptosis and fibrosis. His goal is to develop mechanism-driven radio-immunotherapy strategies and durable FLASH-RT combination regimens that can be translated into clinical trials for breast cancer, improving therapeutic durability, minimizing toxicity, and ultimately enhancing patient outcomes.
Dr. Mutahar’s long-term vision is to establish an independent laboratory at the intersection of radiobiology, immuno-oncology, and translational therapeutics. Guided by Dr. Dirbas’s mentorship and shaped by multidisciplinary experience across three continents, he aims to develop biologically informed treatment strategies that eradicate tumors while preserving normal tissue and immune integrity—ultimately improving quality of life and survival for women with aggressive breast cancers. -
Gabriella Muwanga
Temp - Non-Exempt, Anesthesia - Adult Pain Medicine
BioGabriella Muwanga is a Neurosciences graduate student in the Tawfik and Airan labs at Stanford. She is interested in understanding acute and chronic pain mechanisms and developing therapies for acute and chronic pain through basic and translational research. Gabriella holds a Bachelor of Science in Biomedical Sciences from Makerere University, Kampala, Uganda. She is passionate about teaching, mentorship, science communication, and fostering diversity in science. Outside the lab, she enjoys writing, singing, drawing, Bible Study, and fellowship.
